CN103157076A - Traditional Chinese medicine preparation for treatment of chronic gastritis - Google Patents
Traditional Chinese medicine preparation for treatment of chronic gastritis Download PDFInfo
- Publication number
- CN103157076A CN103157076A CN2011104169316A CN201110416931A CN103157076A CN 103157076 A CN103157076 A CN 103157076A CN 2011104169316 A CN2011104169316 A CN 2011104169316A CN 201110416931 A CN201110416931 A CN 201110416931A CN 103157076 A CN103157076 A CN 103157076A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- treatment
- medicine preparation
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine preparation for the treatment of chronic gastritis and a preparation method thereof. The traditional Chinese medicine preparation is characterized by comprising the following raw materials by weight percentage: 5-15% of codonopsis, 4-12% of tangerine peel, 5-15% of yam, 1-5% of dried ginger, 5-15% of radix scrophulariae, 7-16% of dark plum, 5-15% of radix glehniae, 5-15% of polygonatum kingianum (steamed), 5-15% of white atractylodes rhizome (stir-baked), 5-16% of hawthorn (stir-baked), 5-15% of semen cuscutae (wrap-decocted), 4-12% of bamboo shavings, 5-15% of reed rhizome, 5-15% of dandelion, 5-15% of citrus aurantium, 4-12% of dendrobium, 5-15% of radix ophiopogonis, 4-12% of mint, 5-15% of white peony root, and 4-12% of licorice. The beneficial effects of the traditional Chinese medicine preparation are as follows: either in the dose form of capsules or granules, the traditional Chinese medicine preparation has an exact and significant curative effect for the treatment of chronic superficial gastritis and atrophic gastritis, and is widespread in clinical use, safe and non-toxic side effects; and an appropriate extension of the treatment course of the preparation helps to improve the curative effect on chronic gastritis, so the traditional Chinese medicine preparation is a major breakthrough in traditional Chinese medicines for treatment of chronic gastritis.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly a kind of Chinese medicine preparation for the treatment of chronic gastritis.
Background technology
The modal symptom of chronic gastritis is Upper abdominal pain and glutted.Opposite with Peptic Ulcers pleasant on an empty stomach, uncomfortable after meal, may be because of the diastolic dysfunction of holding, though the few feel satiety of feed.Patient often tells " stomach is weak " or " stomach is soft ".Often cause symptom or make sx↑ because of cold drinks and snachs, hard food, pungent or other irritable foods.These symptoms are difficult for alleviating with antacid and spasmolytic.Most patients tell inappetence.The ratio that chronic gastritis changes into gastric cancer is higher, therefore often be counted as the early stage of gastric cancer.
Chronic gastritis is the disease of a kind of serious harm health and safety.Hemorrhage is also one of the symptom of chronic gastritis, especially merges rotten to the corn.Can be repeatedly small amount bleeding, also can be massive hemorrhage.The emergency gastroscopy prompting, in the cause of disease of upper gastrointestinal hemorrhage, acute or chronic gastritis accounts for 20%~40%.Hemorrhage take melena as common, generally continue hemostasis automatically afterwards in 3~4 days, can send out again after several months or several years.The pathological change of gastritis and symptom are also inconsistent.The inconsistent reason of symptom and biopsy has two probabilities: 1. blindly biopsy fails to get diseased region, does biopsy under fibergastroscope direct-view at present, and positive rate has reached 80%~90%; 2. symptom is not to derive from stomach, may cause due to hepatobiliary system disease.The problem of asymptomatic " Healthy People " biopsy positive, must diagnose gastritis in addition.Because a lot of diseases can be asymptomatic or symptom is slight as Peptic Ulcers, liver cirrhosis, hepatocarcinoma and pulmonary carcinoma etc., pass through physical examination and just be found.Therefore the part Gastritis is asymptomatic.At present, the medicine that is used for the treatment of chronic gastritis is a lot, and as MOLUO DAN, WEIFUCHUN, SANJIU WEITAI etc., although all have certain curative effect, its therapeutic effect is not quite desirable, and curative effect is not high.
Summary of the invention
Technical problem to be solved by this invention is: according to the treatment theory of the traditional Chinese medical science to chronic gastritis, provide a kind of evident in efficacy, the Chinese medicine preparation of the stable and treatment chronic gastritis that has no side effect.
a kind of Chinese medicine preparation for the treatment of chronic gastritis of the present invention, it is characterized in that its raw material components percentage by weight is: Radix Codonopsis: 5-15%, Pericarpium Citri Reticulatae: 4-12%, Rhizoma Dioscoreae: 5-15%, Rhizoma Zingiberis: 1-5%, Radix Scrophulariae: 5-15%, Fructus Mume: 7-16%, Radix Glehniae: 5-15%, Rhizoma Polygonati (steaming): 5-15%, the Rhizoma Atractylodis Macrocephalae (stir-fry): 5-15%, Fructus Crataegi (stir-fry): 5-16%, field dobber (decocting a drug wrapped): 5-15%, Caulis Bambusae In Taenia 4-12%, Rhizoma Phragmitis: 5-15%, Herba Taraxaci: 5-15%, Fructus Aurantii: 5-15%, Herba Dendrobii: 4-12%, Radix Ophiopogonis: 5-15%, Herba Menthae: 4-12%, the Radix Paeoniae Alba: 5-15% Radix Glycyrrhizae: 4-12%.
Described Chinese medicine Radix Codonopsis, Rhizoma Dioscoreae, Rhizoma Polygonati are QI invigorating righting principal agent, and regulating immunological function improves microcirculation and repairs gastric mucosa, and the atrophy body of gland is had restitution.The Rhizoma Atractylodis Macrocephalae can anti-helicobacter pylori, suppresses bile reflux, strengthens the merit of holding up the board stomach reinforcing.Fructus Mume, Fructus Crataegi are promoted the production of body fluid aid digestion, the two-ways regulation Acid Secretion.The hot-tempered crystalline substance of Radix Scrophulariae, Radix Glehniae, field dobber isothermal forms nourishing YIN can supplementing QI and nourishing YIN.Caulis Bambusae In Taenia in the side, Rhizoma Phragmitis are sweet in flavor and cold in property, kind clearing away stomach-heat, and preventing or arresting vomiting is noisy; Herba Taraxaci sweetness and bitterness and trembling with fear, heat-clearing and toxic substances removing is the key medicine of clearing stomach; Fructus Aurantii, the Radix Paeoniae Alba, Herba Menthae is soothing the liver, the easing the affected liver stomach function regulating, promoting the circulation of QI to relieve pain; Herba Dendrobii, Radix Ophiopogonis nourishing stomach-YIN.All medicines share the clearing stomach antiinflammatory, Shugan Zhitong, and campylobacter pyloridis is had good killing action, in order to alimentary canal inflammation.The reparation of ulcer.Therefore the effective prescription for the treatment chronic gastritis.
This preparation is production technology routinely, can be divided into two kinds of dosage forms of capsule and electuary, so that edible.
This preparation has the merit of anti-inflammatory and antalgic, stomach reinforcing QI invigorating, strengthening the body resistance; gastric mucosa and anti-gastric mucosa injury had obvious reparation, protective effect; the lesion degrees such as gastric mucosal erosion, the unrestrained profit of chronic inflammation cell, hyperemia are alleviated or the incidence rate minimizing; alleviate and recover the atrophy of gastric gland body; improve stomach and secrete acid; facilitating digestion liquid and digestive enzyme secretion strengthen gastric motility, strengthen and recovery immunity
Be the patient of chronic superficial gastritis and atrophic gastritis through 60 examples are clarified a diagnosis, be divided at random two groups, take respectively capsule and electuary.Capsules group 30 examples wherein, atrophic gastritis 16 examples have 6 examples to observe half a year, superficial gastritis 14 examples; The oldest 62 years old, minimum 24 years old; The course of disease is the shortest 10 months, and is the longest 20 years; It has 6 examples of remarkable result, resultful 20 examples, unfruitful 4 examples, total effective rate 86.67 (%); Electuary group 80 examples, wherein atrophic gastritis 16 examples, have 7 examples to observe half a year, superficial gastritis 15 examples; The oldest 61 years old, minimum 26 years old, the course of disease is the shortest 6 months, and was the longest 14 years.It has 15 examples of remarkable result, resultful 60 examples, unfruitful 5 examples, total effective rate 93.75 (%).
Through clinical observation more than a year, Chinese medicine preparation of the present invention is find the side effect not, and before and after treatment, check routine blood test, liver, renal function etc. do not find that it has infringement to important organs such as the blood system heart, Liver and kidney; Its safety, property is up to the standards.
In sum, Chinese medicine preparation of the present invention, no matter be capsule or electuary, treatment chronic superficial gastritis and atrophic gastritis all there are definite curative effect and significant effect, clinical application is extensive, safety, and having no side effect, the curative effect proper extension of chronic gastritis is more helped to improve curative effect its course for the treatment of, is the important breakthrough for the treatment of by Chinese herbs chronic gastritis.
The specific embodiment
Embodiment 1:
Get Radix Codonopsis: 5Kg, Rhizoma Dioscoreae: 8kg, Rhizoma Polygonati (steaming): 8kg, Pericarpium Citri Reticulatae: 4kg. Rhizoma Zingiberis: 1kg, Radix Scrophulariae: 5kg, Fructus Mume: 8kg, Radix Glehniae: 5kg, the Rhizoma Atractylodis Macrocephalae (stir-fry): 5kg, Fructus Crataegi (stir-fry): 5kg, field dobber (decocting a drug wrapped): 5kg, Caulis Bambusae In Taenia: 5kg, Rhizoma Phragmitis: 6kg, Herba Taraxaci: 6kg, Fructus Aurantii: 5kg, Herba Dendrobii: 4kg, Radix Ophiopogonis: 4kg, Herba Menthae: 4kg, the Radix Paeoniae Alba: 5kg, Radix Glycyrrhizae: 4kg.
Production technology, make capsule or electuary dosage form routinely.
Embodiment 2:
Get Radix Codonopsis 6kg. Rhizoma Dioscoreae 10kg. Rhizoma Polygonati (steaming) 6kg, the Pericarpium Citri Reticulatae 4kg. Rhizoma Zingiberis 2kg. Radix Scrophulariae 5kg. Fructus Mume 6kg. Radix Glehniae 5kg. Rhizoma Atractylodis Macrocephalae (stir-fry) 5kg. Fructus Crataegi (stir-fry) 6kg. field dobber (decocting a drug wrapped) 5kg, Caulis Bambusae In Taenia: 4kg, Rhizoma Phragmitis: 6kg, Herba Taraxaci: 4kg, Fructus Aurantii: 4kg, Herba Dendrobii: 4kg, Radix Ophiopogonis: 5kg, Herba Menthae: 4kg, the Radix Paeoniae Alba: 5kg, Radix Glycyrrhizae: 4kg.
Production technology, make capsule or electuary dosage form routinely.
Embodiment 3:
Get Radix Codonopsis 8kg. Rhizoma Dioscoreae 5kg_ Rhizoma Polygonati (steaming) the 5kg_ Pericarpium Citri Reticulatae 5kg. Rhizoma Zingiberis 3kg. Radix Scrophulariae 5kg. Fructus Mume 5kg. Radix Glehniae 5kg. Rhizoma Atractylodis Macrocephalae (stir-fry) 6kg. Fructus Crataegi (stir-fry) 6kg. field dobber (decocting a drug wrapped) 6kg, Caulis Bambusae In Taenia 8kg, Rhizoma Phragmitis: 8kg, Herba Taraxaci: 5kg, Fructus Aurantii: 5kg, Herba Dendrobii: 4kg, Radix Ophiopogonis: 5kg, Herba Menthae: 5kg, the Radix Paeoniae Alba: 5kg, Radix Glycyrrhizae: 5kg.
Connect conventional production process and make capsule or electuary dosage form.
Claims (2)
1. Chinese medicine preparation for the treatment of chronic gastritis, it is characterized in that its raw material components percentage by weight is: Radix Codonopsis: 5-15%, Pericarpium Citri Reticulatae: 4-12%, Rhizoma Dioscoreae: 5-15%, Rhizoma Zingiberis: 1-5%, Radix Scrophulariae: 5-15%, Fructus Mume: 7-16%, Radix Glehniae: 5-15%, Rhizoma Polygonati (steaming): 5-15%, the Rhizoma Atractylodis Macrocephalae (stir-fry): 5-15%, Fructus Crataegi (stir-fry): 5-16%, field dobber (decocting a drug wrapped): 5-15%, Caulis Bambusae In Taenia 8-12%, Rhizoma Phragmitis: 8-15%, Herba Taraxaci: 5-15%, Fructus Aurantii: 5-15%, Herba Dendrobii: 5-12%, Radix Ophiopogonis: 5-15%, Herba Menthae: 5-12%, the Radix Paeoniae Alba: 5-15% Radix Glycyrrhizae: 5-12%.
2. a kind of Chinese medicine preparation for the treatment of chronic gastritis as claimed in claim 1, is characterized in that described preparation is capsule and two kinds of dosage forms of electuary.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104169316A CN103157076A (en) | 2011-12-13 | 2011-12-13 | Traditional Chinese medicine preparation for treatment of chronic gastritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011104169316A CN103157076A (en) | 2011-12-13 | 2011-12-13 | Traditional Chinese medicine preparation for treatment of chronic gastritis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103157076A true CN103157076A (en) | 2013-06-19 |
Family
ID=48580941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011104169316A Pending CN103157076A (en) | 2011-12-13 | 2011-12-13 | Traditional Chinese medicine preparation for treatment of chronic gastritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103157076A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104524516A (en) * | 2014-12-29 | 2015-04-22 | 安徽中医药大学第一附属医院 | Traditional Chinese medicine composition for treating liver stagnation and spleen deficiency type chronic atrophic gastritis |
CN104771742A (en) * | 2015-04-24 | 2015-07-15 | 王永帮 | Traditional Chinese medicine composition for treating stomachache |
CN105412564A (en) * | 2015-12-10 | 2016-03-23 | 杨献美 | Method for preparing pharmaceutic preparation for treating spleen-deficiency stomach-weakness type chronic gastritis |
CN110339330A (en) * | 2019-07-25 | 2019-10-18 | 河南中医药大学 | A kind of Chewable Tablets of Chinese traditional medicine for treating superficial gastritis |
CN113413366A (en) * | 2021-06-30 | 2021-09-21 | 宁夏医科大学 | Dry-suspension oral in-situ gel for treating chronic gastritis and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1387889A (en) * | 2002-06-15 | 2003-01-01 | 合肥神鹿双鹤药业有限责任公司 | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis |
CN101036758A (en) * | 2007-04-17 | 2007-09-19 | 乔兴茂 | Chinese traditional medicine composition took orally for treating chronic superficial gastritis |
KR20110056909A (en) * | 2009-11-23 | 2011-05-31 | 주식회사 티제이네츄럴 | Composition of mixed herb medicine for chicken boiled with rice and milk vetch root |
-
2011
- 2011-12-13 CN CN2011104169316A patent/CN103157076A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1387889A (en) * | 2002-06-15 | 2003-01-01 | 合肥神鹿双鹤药业有限责任公司 | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis |
CN101036758A (en) * | 2007-04-17 | 2007-09-19 | 乔兴茂 | Chinese traditional medicine composition took orally for treating chronic superficial gastritis |
KR20110056909A (en) * | 2009-11-23 | 2011-05-31 | 주식회사 티제이네츄럴 | Composition of mixed herb medicine for chicken boiled with rice and milk vetch root |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104524516A (en) * | 2014-12-29 | 2015-04-22 | 安徽中医药大学第一附属医院 | Traditional Chinese medicine composition for treating liver stagnation and spleen deficiency type chronic atrophic gastritis |
CN104771742A (en) * | 2015-04-24 | 2015-07-15 | 王永帮 | Traditional Chinese medicine composition for treating stomachache |
CN105412564A (en) * | 2015-12-10 | 2016-03-23 | 杨献美 | Method for preparing pharmaceutic preparation for treating spleen-deficiency stomach-weakness type chronic gastritis |
CN110339330A (en) * | 2019-07-25 | 2019-10-18 | 河南中医药大学 | A kind of Chewable Tablets of Chinese traditional medicine for treating superficial gastritis |
CN113413366A (en) * | 2021-06-30 | 2021-09-21 | 宁夏医科大学 | Dry-suspension oral in-situ gel for treating chronic gastritis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988656B (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
CN104771707A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
CN103157076A (en) | Traditional Chinese medicine preparation for treatment of chronic gastritis | |
CN104587298A (en) | Traditional Chinese medicinal composition for treating pulmonary abscess | |
CN101757336A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
CN104399039A (en) | Medicament for treating ulcerative colitis and preparation method thereof | |
CN101690787B (en) | Traditional Chinese medicine for treating chronic gastritis and gastric ulcer | |
CN102600433A (en) | Traditional Chinese medicine combination for curing gastro-esophageal reflux disease | |
CN102698150B (en) | Oral administration traditional Chinese medicine composition for treating ulcerative colitis | |
CN104189368A (en) | Traditional Chinese medicinal composition for treating spleen and stomach diseases and preparation method thereof | |
CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
CN103230518B (en) | Traditional Chinese medical composition for treating peptic ulcer | |
CN104984237A (en) | Traditional Chinese medicine composition and preparation method | |
CN104840927A (en) | Traditional Chinese medicine for treating chronic erosive gastritis | |
CN104771657A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
CN1242800C (en) | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis | |
CN100450523C (en) | Chinese materia medica preparation for treating gastric disease | |
CN101884714B (en) | Chinese medicinal decoction for treating urticaria | |
CN107802795B (en) | Traditional Chinese medicine jaundice-removing enema for treating icteric hepatitis and preparation method thereof | |
CN106581576A (en) | Traditional Chinese medicine composition for protecting liver and promoting gallbladder | |
CN106309794A (en) | Traditional Chinese medicine composition for treating epigastric pain due to chronic gastritis and preparation method thereof | |
CN101176768A (en) | Epityphlon health | |
CN104524283A (en) | Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis | |
CN105148209A (en) | Chinese herb composition for treating dysentery | |
CN104758455A (en) | Traditional Chinese medicine composition for treating chronic gastritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130619 |
|
RJ01 | Rejection of invention patent application after publication |